NCT06091202

Brief Summary

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
608

participants targeted

Target at P75+ for phase_3 chronic-pain

Timeline
13mo left

Started Jul 2024

Longer than P75 for phase_3 chronic-pain

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Jul 2024Jun 2027

First Submitted

Initial submission to the registry

October 13, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 19, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

July 11, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

July 20, 2025

Status Verified

June 1, 2025

Enrollment Period

2.8 years

First QC Date

October 13, 2023

Last Update Submit

July 16, 2025

Conditions

Keywords

RuralPainCIHVeteran

Outcome Measures

Primary Outcomes (1)

  • Pain Interference - Brief Pain Inventory (BPI)

    Pain Interference subscale from the Brief Pain Inventory. Scores are reported on a range of 0 - 10, with higher scores indicating more impairment due to pain.

    Baseline, 3-, 6-, 9-, and 12 Months

Secondary Outcomes (8)

  • Pain Intensity - Brief Pain Inventory (BPI)

    Baseline, 3-, 6-, 9-, and 12 Months

  • Physical Functioning - PROMIS Physical Functioning Scale

    Baseline, 3-, 6-, 9-, and 12 Months

  • Quality of Life - Veterans RAND-12 (VR-12)

    Baseline, 3-, 6-, 9-, and 12 Months

  • Depressive Symptoms - Patient Health Questionnaire-9 (PHQ-9)

    Baseline, 3-, 6-, 9-, and 12 Months

  • Anxiety Symptoms - Generalized Anxiety Disorder-7 (GAD-7)

    Baseline, 3-, 6-, 9-, and 12 Months

  • +3 more secondary outcomes

Study Arms (2)

CORPs Intervention

ACTIVE COMPARATOR

The CORPs Intervention is a nurse-led intervention. A) An intake assessment with a Nurse Care Manager at the start of the study by phone or video to discuss the patient's pain experience, care options, and goals. Resources are provided and focus on non-medication options at the VA, and as appropriate, in the community. B) 5 Check-in phone/video appointments with a Nurse Care Manager, scheduled to take place near 2-, 4-, 8-, 12-, and 16-weeks. These visits will provide further assistance with goal planning and care coordination for pain management. C) Optional 6-week virtual group education class covering topics like complementary and integrative approaches to pain, sleep and pain, and the neurobiology of pain. D) Patients in this arm can contact their nurse with questions for the full 12 months of participation.

Behavioral: CORPs Intervention

Minimally Enhanced Usual Care (MEUC)

PLACEBO COMPARATOR

The minimally enhanced usual care arm is a one-time education session. A) One-time education session with a Nurse Care Manager by phone/video to review pain resources. These resources focus on non-medication options at the VA, and as appropriate, in the community.

Behavioral: Minimally Enhanced Usual Care (MEUC)

Interventions

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

Also known as: Nurse-led collaborative care
CORPs Intervention

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

Also known as: One-time Education Session
Minimally Enhanced Usual Care (MEUC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • U.S. Veteran
  • Rural Residence based on Rural Urban Commuting Area codes
  • High Impact Chronic pain, determined through a phone screening
  • Access to landline or cell phone
  • English Speaking

You may not qualify if:

  • Cognitive impairment that would impact participation in the study
  • Plans to move in the next 3 months
  • Surgery in the past 3 months
  • In long-term inpatient or hospice care
  • Terminal illness (defined as life expectancy of less than 12 months)
  • Active participation in another pain intervention study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

VA Minneapolis Health Care System

Minneapolis, Minnesota, 55417, United States

RECRUITING

VA Portland Health Care System

Portland, Oregon, 97239, United States

RECRUITING

VA Tennessee Valley Health Care System

Nashville, Tennessee, 37212, United States

RECRUITING

VA North Texas Health Care System

Dallas, Texas, 75216, United States

RECRUITING

MeSH Terms

Conditions

Chronic PainPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Travis Lovejoy, PhD, MPH

    Oregon Health & Science University, VA Portland Health Care System

    PRINCIPAL INVESTIGATOR
  • Benjamin Morasco, PhD

    Oregon Health & Science University, VA Portland Health Care System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Natassja Pal, BS

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 13, 2023

First Posted

October 19, 2023

Study Start

July 11, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

July 20, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations